Cholestatic hepatitis from erythromycin ethylsuccinate report of two cases

Anna Mae Diehl; Patricia Latham; John K. Boitnott; John Mann; Willis C. Maddrey

doi:10.1016/0002-9343(84)91013-1

Cholestatic hepatitis from erythromycin ethylsuccinate report of two cases

Anna Mae Diehl, Patricia Latham, John K. Boitnott, John Mann, Willis C. Maddrey

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Cholestatic hepatitis developed in two patients while they were receiving erythromycin ethylsuccinate. Both patients had received the drug without apparent problem within two months of the episode of drug-related Cholestatic injury. In both, there was complete resolution of the hepatic injury upon withdrawal of the drug. Erythromycin ethylsuccinate should be added to the list of drugs causing Cholestatic hepatitis.

Original language	English (US)
Pages (from-to)	931-934
Number of pages	4
Journal	The American Journal of Medicine
Volume	76
Issue number	5
DOIs	https://doi.org/10.1016/0002-9343(84)91013-1
State	Published - May 1984

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/0002-9343(84)91013-1

Cite this

@article{e0334b94b7ba4a14bb0a9f5861e8b300,

title = "Cholestatic hepatitis from erythromycin ethylsuccinate report of two cases",

abstract = "Cholestatic hepatitis developed in two patients while they were receiving erythromycin ethylsuccinate. Both patients had received the drug without apparent problem within two months of the episode of drug-related Cholestatic injury. In both, there was complete resolution of the hepatic injury upon withdrawal of the drug. Erythromycin ethylsuccinate should be added to the list of drugs causing Cholestatic hepatitis.",

author = "Diehl, {Anna Mae} and Patricia Latham and Boitnott, {John K.} and John Mann and Maddrey, {Willis C.}",

year = "1984",

month = may,

doi = "10.1016/0002-9343(84)91013-1",

language = "English (US)",

volume = "76",

pages = "931--934",

journal = "American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Cholestatic hepatitis from erythromycin ethylsuccinate report of two cases

AU - Diehl, Anna Mae

AU - Latham, Patricia

AU - Boitnott, John K.

AU - Mann, John

AU - Maddrey, Willis C.

PY - 1984/5

Y1 - 1984/5

N2 - Cholestatic hepatitis developed in two patients while they were receiving erythromycin ethylsuccinate. Both patients had received the drug without apparent problem within two months of the episode of drug-related Cholestatic injury. In both, there was complete resolution of the hepatic injury upon withdrawal of the drug. Erythromycin ethylsuccinate should be added to the list of drugs causing Cholestatic hepatitis.

AB - Cholestatic hepatitis developed in two patients while they were receiving erythromycin ethylsuccinate. Both patients had received the drug without apparent problem within two months of the episode of drug-related Cholestatic injury. In both, there was complete resolution of the hepatic injury upon withdrawal of the drug. Erythromycin ethylsuccinate should be added to the list of drugs causing Cholestatic hepatitis.

UR - http://www.scopus.com/inward/record.url?scp=0021354682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021354682&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(84)91013-1

DO - 10.1016/0002-9343(84)91013-1

M3 - Article

C2 - 6609640

AN - SCOPUS:0021354682

SN - 0002-9343

VL - 76

SP - 931

EP - 934

JO - American Journal of Medicine

JF - American Journal of Medicine

IS - 5

ER -

Cholestatic hepatitis from erythromycin ethylsuccinate report of two cases

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this